Swixx BioPharma's innovative approach involves fully replacing the subsidiaries or business units of major biopharma, over-the-counter (OTC), and medical device multinationals in the regions or therapeutic areas they choose not to enter or have decided to exit. This unique business model has drawn the attention of investors, with the latest venture round investment being secured on 08 December 2021. The investment came from HBM Healthcare Investments, demonstrating confidence in Swixx BioPharma's potential to revolutionize the pharmaceutical industry within the CEE region. This latest injection of capital positions the company well to further advance its mission and solidify its presence in the market.
Swixx BioPharma
Founded 2014
Baar, Switzerland
734 employees
Series Unknown
Total: $102.00M
Biopharma, Biotechnology +1
Baar, Switzerland
734 employees
Series Unknown
Total: $102.00M
Biopharma, Biotechnology +1
General Information
Get notified when Swixx BioPharma moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Swixx BioPharma
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Switzerland Market
Biopharma
About Swixx BioPharma
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
08 Dec 2021 |
| Venture Round | •••••• | 2 |
|
20 May 2021 |
| Debt Financing | •••••• | 3 |
|
04 Mar 2021 |
| Venture Round | •••••• | 1 |
|
27 Nov 2020 |
| Debt Financing | •••••• | 1 |
|
05 Feb 2020 |
Swixx BioPharma Alternatives & Competitors
Swixx BioPharma vs
Biopharma Informatic
United States
Advancing Medicine Through Clinical Research
61 employees
Biotechnology
Swixx BioPharma vs
Alpha Biopharma
China
Specialized in drug innovation from clinical development to commercialization success.
Series B
5 employees
Biopharma, Health Care
Swixx BioPharma vs
Exemplify Biopharma, Inc., a Symeres Company
United States
Advancing Drug Development with CMC Consulting and Laboratory Expertise, All Under One Roof
19 employees
Analytics, Biopharma
FAQ About Swixx BioPharma
Swixx BioPharma is designed to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit
Swixx BioPharma was founded in 2014.
Swixx BioPharma is headquartered in Baar, Switzerland.
Swixx BioPharma operates in the following industries: Biopharma, Biotechnology, Life Sciences.
Swixx BioPharma has approximately 734 employees.
Swixx BioPharma has completed 5 funding rounds, raising a total of $102.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Swixx BioPharma include Biopharma Informatic, Alpha Biopharma, Exemplify Biopharma, Inc., a Symeres Company, Adnexi, BioScience Advisors. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Swixx BioPharma and Biopharma Informatic are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Swixx BioPharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
